rs117017020
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001961.4(EEF2):āc.2175A>Gā(p.Ala725=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00077 in 1,591,624 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.00095 ( 4 hom., cov: 32)
Exomes š: 0.00075 ( 10 hom. )
Consequence
EEF2
NM_001961.4 synonymous
NM_001961.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.93
Genes affected
EEF2 (HGNC:3214): (eukaryotic translation elongation factor 2) This gene encodes a member of the GTP-binding translation elongation factor family. This protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the nascent protein chain from the A-site to the P-site of the ribosome. This protein is completely inactivated by EF-2 kinase phosporylation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 19-3977503-T-C is Benign according to our data. Variant chr19-3977503-T-C is described in ClinVar as [Benign]. Clinvar id is 585828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3977503-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.93 with no splicing effect.
BS2
High AC in GnomAd4 at 145 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EEF2 | NM_001961.4 | c.2175A>G | p.Ala725= | synonymous_variant | 13/15 | ENST00000309311.7 | NP_001952.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EEF2 | ENST00000309311.7 | c.2175A>G | p.Ala725= | synonymous_variant | 13/15 | 5 | NM_001961.4 | ENSP00000307940 | P1 | |
EEF2 | ENST00000600794.1 | c.107+525A>G | intron_variant | 3 | ENSP00000471265 |
Frequencies
GnomAD3 genomes AF: 0.000887 AC: 135AN: 152178Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
135
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00179 AC: 397AN: 222102Hom.: 5 AF XY: 0.00210 AC XY: 254AN XY: 121068
GnomAD3 exomes
AF:
AC:
397
AN:
222102
Hom.:
AF XY:
AC XY:
254
AN XY:
121068
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000751 AC: 1081AN: 1439328Hom.: 10 Cov.: 33 AF XY: 0.000881 AC XY: 630AN XY: 715462
GnomAD4 exome
AF:
AC:
1081
AN:
1439328
Hom.:
Cov.:
33
AF XY:
AC XY:
630
AN XY:
715462
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000952 AC: 145AN: 152296Hom.: 4 Cov.: 32 AF XY: 0.00115 AC XY: 86AN XY: 74464
GnomAD4 genome
AF:
AC:
145
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
86
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
109
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 23, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 01, 2023 | - - |
EEF2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at